| Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO/ARO/AIO-94 trial E Fokas, T Liersch, R Fietkau, W Hohenberger, T Beissbarth, C Hess, ... Journal of Clinical Oncology 32 (15), 1554-1562, 2014 | 490 | 2014 |
| Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation E Fokas, R Prevo, JR Pollard, PM Reaper, PA Charlton, B Cornelissen, ... Cell death & disease 3 (12), e441-e441, 2012 | 469 | 2012 |
| Randomized phase II trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO/ARO/AIO-12 E Fokas, M Allgäuer, B Polat, G Klautke, GG Grabenbauer, R Fietkau, ... Journal of Clinical Oncology 37 (34), 3212-3222, 2019 | 461 | 2019 |
| Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer P Balermpas, Y Michel, J Wagenblast, O Seitz, C Weiß, F Rödel, C Rödel, ... British journal of cancer 110 (2), 501-509, 2014 | 346 | 2014 |
| The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy R Prevo, E Fokas, PM Reaper, PA Charlton, JR Pollard, WG McKenna, ... Cancer biology & therapy 13 (11), 1072-1081, 2012 | 274 | 2012 |
| Targeting ATR in DNA damage response and cancer therapeutics E Fokas, R Prevo, EM Hammond, TB Brunner, WG McKenna, RJ Muschel Cancer treatment reviews 40 (1), 109-117, 2014 | 242 | 2014 |
| CD 8+ tumour‐infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre … P Balermpas, F Rödel, C Rödel, M Krause, A Linge, F Lohaus, ... International journal of cancer 138 (1), 171-181, 2016 | 239 | 2016 |
| Ion beam radiobiology and cancer: time to update ourselves E Fokas, G Kraft, H An, R Engenhart-Cabillic Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1796 (2), 216-229, 2009 | 239 | 2009 |
| Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for patients with locally advanced rectal cancer: long-term results of the CAO/ARO … E Fokas, A Schlenska-Lange, B Polat, G Klautke, GG Grabenbauer, ... JAMA oncology 8 (1), e215445-e215445, 2022 | 232 | 2022 |
| The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia TM Ashton, E Fokas, LA Kunz-Schughart, LK Folkes, S Anbalagan, ... Nature communications 7 (1), 12308, 2016 | 212 | 2016 |
| PD‐L1 blockade enhances response of pancreatic ductal adenocarcinoma to radiotherapy A Azad, S Yin Lim, Z D'Costa, K Jones, A Diana, OJ Sansom, P Kruger, ... EMBO molecular medicine 9 (2), 167-180, 2017 | 207 | 2017 |
| Metastasis: the seed and soil theory gains identity E Fokas, R Engenhart-Cabillic, K Daniilidis, F Rose, HX An Cancer and Metastasis Reviews 26, 705-715, 2007 | 200 | 2007 |
| Hypofractionated stereotactic reirradiation of recurrent glioblastomas E Fokas, U Wacker, MW Gross, M Henzel, E Encheva, ... Strahlentherapie und Onkologie 185 (4), 235, 2009 | 185 | 2009 |
| Inflammatory fibroblasts mediate resistance to neoadjuvant therapy in rectal cancer AM Nicolas, M Pesic, E Engel, PK Ziegler, M Diefenhardt, KB Kennel, ... Cancer cell 40 (2), 168-184. e13, 2022 | 175 | 2022 |
| Dual inhibition of the PI3K/mTOR pathway increases tumor radiosensitivity by normalizing tumor vasculature E Fokas, JH Im, S Hill, S Yameen, M Stratford, J Beech, W Hackl, ... Cancer research 72 (1), 239-248, 2012 | 160 | 2012 |
| International consensus recommendations on key outcome measures for organ preservation after (chemo) radiotherapy in patients with rectal cancer E Fokas, A Appelt, R Glynne-Jones, G Beets, R Perez, J Garcia-Aguilar, ... Nature Reviews Clinical Oncology 18 (12), 805-816, 2021 | 153 | 2021 |
| Tumor regression grading after preoperative chemoradiotherapy as a prognostic factor and individual-level surrogate for disease-free survival in rectal cancer E Fokas, P Ströbel, R Fietkau, M Ghadimi, T Liersch, GG Grabenbauer, ... JNCI: Journal of the National Cancer Institute 109 (12), djx095, 2017 | 153 | 2017 |
| Stereotactic radiosurgery and fractionated stereotactic radiotherapy: comparison of efficacy and toxicity in 260 patients with brain metastases E Fokas, M Henzel, G Surber, G Kleinert, K Hamm, R Engenhart-Cabillic Journal of neuro-oncology 109, 91-98, 2012 | 132 | 2012 |
| The prognostic role of desmoplastic stroma in pancreatic ductal adenocarcinoma LM Wang, MA Silva, Z D'Costa, R Bockelmann, Z Soonawalla, S Liu, ... Oncotarget 7 (4), 4183, 2016 | 128 | 2016 |
| Increased expression of EphA2 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients LF Wang, E Fokas, M Bieker, F Rose, P Rexin, Y Zhu, A Pagenstecher, ... Oncology reports 19 (1), 151-156, 2008 | 126 | 2008 |
